Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis

Z Saidak, PJ Marie - Pharmacology & therapeutics, 2012 - Elsevier
Osteoporosis is an important age-related bone disease characterized by increased bone
turnover with insufficient bone formation relative to bone resorption. According to the current …

Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives

R Baron, E Hesse - The Journal of Clinical Endocrinology & …, 2012 - academic.oup.com
Osteoporosis is defined as low bone mineral density associated with skeletal fractures
secondary to minimal or no trauma, most often involving the spine, the hip, and the forearm …

Physiological and pharmacological roles of PTH and PTHrP in bone using their shared receptor, PTH1R

TJ Martin, NA Sims, E Seeman - Endocrine reviews, 2021 - academic.oup.com
Parathyroid hormone (PTH) and the paracrine factor, PTH-related protein (PTHrP), have
preserved in evolution sufficient identities in their amino-terminal domains to share …

Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases

TJ Martin - Physiological reviews, 2016 - journals.physiology.org
Although parathyroid hormone-related protein (PTHrP) was discovered as a cancer-derived
hormone, it has been revealed as an important paracrine/autocrine regulator in many …

The calcium-sensing receptor beyond extracellular calcium homeostasis: conception, development, adult physiology, and disease

D Riccardi, PJ Kemp - Annual review of physiology, 2012 - annualreviews.org
The extracellular calcium-sensing receptor (CaSR) is the first identified G protein–coupled
receptor to be activated by an ion, extracellular calcium (Ca2+). Since the identification of …

Stem cells in osteoporosis: from biology to new therapeutic approaches

V Paspaliaris, G Kolios - Stem Cells International, 2019 - Wiley Online Library
Osteoporosis is a systemic disease that affects the skeleton, causing reduction of bone
density and mass, resulting in destruction of bone microstructure and increased risk of bone …

Calcimimetic and calcilytic drugs: feats, flops, and futures

EF Nemeth, WG Goodman - Calcified Tissue International, 2016 - Springer
The actions of extracellular Ca 2+ in regulating parathyroid gland and kidney functions are
mediated by the extracellular calcium receptor (CaR), a G protein-coupled receptor. The …

The calcium-sensing receptor in bone metabolism: from bench to bedside and back

L Cianferotti, AR Gomes, S Fabbri, A Tanini… - Osteoporosis …, 2015 - Springer
The calcium-sensing receptor (CaSR), a key player in the maintenance of calcium
homeostasis, can influence bone modeling and remodeling by directly acting on bone cells …

Synthesis and biological activities of drugs for the treatment of osteoporosis

S Zhou, G Huang, G Chen - European journal of medicinal chemistry, 2020 - Elsevier
Osteoporosis is an asymptomatic progressive disease. With the improvement of people's
living standard and the aging of population, osteoporosis and its fracture have become one …

Bone biology and anabolic therapies for bone: current status and future prospects

TJ Martin - Journal of bone metabolism, 2014 - synapse.koreamed.org
Bone is continuously remodelled at many sites asynchronously throughout the skeleton, with
bone formation and resorption balanced at these sites to retain bone structure. Negative …